⌘K

Login Start Free

Home/Filings/4/0001209191-23-016050

4//SEC Filing

ONEILL ALISON 4

Accession 0001209191-23-016050

CIK 0001718108other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:00 PM ET

Size

5.3 KB

Accession

0001209191-23-016050

Insider Transaction Report

Form 4

Period: 2023-03-01

Surface Oncology, Inc.SURF

CHIEF MEDICAL OFFICER

Transactions

Award
Stock Option (Right to Buy)
2023-03-01+150,000→ 150,000 total
Exercise: $0.69Exp: 2033-03-01→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The Options shall vest in full on February 8, 2024, so long as the reporting person remains an employee or other service provider of the Issuer on such date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother

Related Parties

1

filerCIK 0001283882

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 8:00 PM ET
Size: 5.3 KB

View on SEC.gov